Asset Manager

Updated:

CARB-X

CARB-X directs public and philanthropic capital into early-stage antimicrobial resistance projects from Boston.

CARB-X logo

CARB-X

CARB-X is a global non-profit partnership founded in 2016 in Boston, Massachusetts. It accelerates antibacterial products to address drug-resistant bacteria. CARB-X's portfolio includes a diverse pipeline of new antibiotics, vaccines, rapid diagnostics, and other products.

General information

Firm type

Generalist

Year founded

AUM

Undisclosed

Location

Region

North America

Country

United States

City

Boston

Corporate office

Boston, MA, United States

Principals

Kevin Outterson

Executive Director

Andy Soares White

Chief Financial Officer

Sector focus

Healthcare Services

Frequently asked questions

Who runs investment decisions at CARB-X?

Kevin Outterson serves as Executive Director and oversees project selection. Andy Soares White manages financial operations as Chief Financial Officer.

How does CARB-X source proprietary deal flow?

CARB-X receives applications through open calls and referrals from BARDA, NIAID, and partner foundations. Technical review panels evaluate proposals for scientific merit and development stage.

Does CARB-X participate in fund commitments or only direct deals?

CARB-X provides direct project funding and in-kind support rather than committing to external funds. Awards typically take the form of milestone-based grants.

What investment stages does CARB-X typically target?

The firm focuses on seed, start-up, and growth stages within early-stage antimicrobial resistance development.

Where does the underlying capital come from?

Primary funding originates from BARDA, with co-funding from Wellcome Trust, the Bill & Melinda Gates Foundation, and Novo Nordisk Foundation.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on asset managers?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Boston Generalist profiles